Switch theme
Sign up to access all valuation multiples
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.
2015
2.4K+
LTM Revenue $845M
LTM EBITDA $29.1M
$557M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
InnovAge has a last 12-month revenue (LTM) of $845M and a last 12-month EBITDA of $29.1M.
In the most recent fiscal year, InnovAge achieved revenue of $764M and an EBITDA of $1.2M.
InnovAge expects next 12-month revenue of XXX and NTM EBITDA of XXX
See InnovAge valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $845M | XXX | $764M | XXX | XXX | XXX |
| Gross Profit | $367M | XXX | $132M | XXX | XXX | XXX |
| Gross Margin | 43% | XXX | 17% | XXX | XXX | XXX |
| EBITDA | $29.1M | XXX | $1.2M | XXX | XXX | XXX |
| EBITDA Margin | 3% | XXX | 0% | XXX | XXX | XXX |
| EBIT | -$20.5M | XXX | -$23.2M | XXX | XXX | XXX |
| EBIT Margin | -2% | XXX | -3% | XXX | XXX | XXX |
| Net Profit | -$31.2M | XXX | -$21.3M | XXX | XXX | XXX |
| Net Margin | -4% | XXX | -3% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $8.3M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, InnovAge's stock price is $4.
InnovAge has current market cap of $554M, and EV of $557M.
See InnovAge trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $557M | $554M | XXX | XXX | XXX | XXX | $-0.17 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, InnovAge has market cap of $554M and EV of $557M.
InnovAge's trades at 0.7x EV/Revenue multiple, and 35.5x EV/EBITDA.
Equity research analysts estimate InnovAge's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
InnovAge has a P/E ratio of -17.7x.
See valuation multiples for InnovAge and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $554M | XXX | $554M | XXX | XXX | XXX |
| EV (current) | $557M | XXX | $557M | XXX | XXX | XXX |
| EV/Revenue | 0.7x | XXX | 0.7x | XXX | XXX | XXX |
| EV/EBITDA | 19.1x | XXX | 35.5x | XXX | XXX | XXX |
| EV/EBIT | -27.2x | XXX | -25.4x | XXX | XXX | XXX |
| EV/Gross Profit | 1.5x | XXX | n/a | XXX | XXX | XXX |
| P/E | -17.7x | XXX | -20.7x | XXX | XXX | XXX |
| EV/FCF | 163.6x | XXX | -29.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialInnovAge's last 12 month revenue growth is 10%
InnovAge's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
InnovAge's rule of 40 is 8% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
InnovAge's rule of X is 29% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for InnovAge and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Margin | 3% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Growth | 57% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | 8% | XXX | 12% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 29% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 3% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 20% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| National Healthcare Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| Regis Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Maternus-Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| Addus HomeCare | XXX | XXX | XXX | XXX | XXX | XXX |
| Amedisys | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
InnovAge acquired XXX companies to date.
Last acquisition by InnovAge was XXXXXXXX, XXXXX XXXXX XXXXXX . InnovAge acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was InnovAge founded? | InnovAge was founded in 2015. |
| Where is InnovAge headquartered? | InnovAge is headquartered in United States of America. |
| How many employees does InnovAge have? | As of today, InnovAge has 2.4K+ employees. |
| Who is the CEO of InnovAge? | InnovAge's CEO is Mr. Patrick Blair. |
| Is InnovAge publicy listed? | Yes, InnovAge is a public company listed on NAS. |
| What is the stock symbol of InnovAge? | InnovAge trades under INNV ticker. |
| When did InnovAge go public? | InnovAge went public in 2021. |
| Who are competitors of InnovAge? | Similar companies to InnovAge include e.g. National Healthcare Corp, Regis Healthcare, Maternus-Kliniken, Addus HomeCare. |
| What is the current market cap of InnovAge? | InnovAge's current market cap is $554M |
| What is the current revenue of InnovAge? | InnovAge's last 12 months revenue is $845M. |
| What is the current revenue growth of InnovAge? | InnovAge revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of InnovAge? | Current revenue multiple of InnovAge is 0.7x. |
| Is InnovAge profitable? | Yes, InnovAge is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of InnovAge? | InnovAge's last 12 months EBITDA is $29.1M. |
| What is InnovAge's EBITDA margin? | InnovAge's last 12 months EBITDA margin is 3%. |
| What is the current EV/EBITDA multiple of InnovAge? | Current EBITDA multiple of InnovAge is 19.1x. |
| What is the current FCF of InnovAge? | InnovAge's last 12 months FCF is $3.4M. |
| What is InnovAge's FCF margin? | InnovAge's last 12 months FCF margin is 0%. |
| What is the current EV/FCF multiple of InnovAge? | Current FCF multiple of InnovAge is 163.6x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
